Diandra “Fu” Debrosse Zimmermann Becomes First Black Woman Ever Appointed to Lead a Multidistrict Litigation with Co-Lead Counsel Selection in Baby Formula MDL

Rhea-AI Summary

Diandra Debrosse Zimmermann has made legal history as the first black woman appointed co-lead counsel in a massive products liability case against Abbott Laboratories (NYSE: ABT) and Mead Johnson. This multidistrict litigation involves over 60 lawsuits claiming that formulas like Similac, used for premature infants, led to necrotizing enterocolitis (NEC). Zimmermann emphasized the need for accountability from these corporations, citing their awareness of the risks associated with their products. The case is currently in the United States District Court for the Northern District of Illinois.

Positive

• Diandra Debrosse Zimmermann appointed as first black female co-lead counsel, highlighting diversity in legal representation.
• The litigation could potentially hold Abbott Laboratories accountable for alleged negligence, impacting investor sentiment positively.

Negative

• The ongoing legal challenges could lead to financial liabilities for Abbott Laboratories if the court rules against them.

DiCello Levitt partner makes legal history as part of plaintiffs’ co-lead counsel group in massive products liability case against Abbott Laboratories and Mead Johnson

CHICAGO--(BUSINESS WIRE)-- Diandra “Fu” Debrosse Zimmermann made legal history today, becoming the first black woman ever appointed plaintiffs’ co-lead counsel in a multidistrict litigation. Debrosse Zimmermann was appointed to the role in the massive products liability MDL, In Re: Abbott Laboratories, et al., Preterm Infant Nutrition Products Liability Litigation, against two of the world’s largest manufacturers of infant formula, Abbott Laboratories (NYSE: ABT) and Mead Johnson. Comprised of more than 60 state and federal lawsuits filed across the U.S., the case stems from allegations against the manufacturers of infant formulas Similac (Abbott) and Enfamil (Mead) by parents of premature infants who were fed with that formula and developed the deadly neonatal condition, necrotizing enterocolitis (NEC).

Debrosse Zimmermann, managing partner of national plaintiff’s law firm, DiCello Levitt’s Birmingham, Ala. office, and co-managing partner of its Washington D.C. office, joins a diverse co-lead counsel group that includes Timothy J. Becker, C. Andrew Childers, Wendy R. Fleishman, and Jose M. Rojas, in representing plaintiffs across the United States in the multidistrict litigation against the nation’s two largest infant formula producers.

“It’s an honor and a privilege to have been appointed to a co-lead counsel position in this important litigation as we seek justice against these corporate giants who flat-out ignored the harm their products were causing innocent newborns,” Debrosse Zimmermann said. “Abbott and Mead Johnson have long been aware of the scientific evidence that their formulas greatly increased the risk of NEC in premature infants, yet they failed to take the most basic actions that could have saved many young lives. It is these infants and their families for whom my co-lead counsel and I are committed to achieving justice.”

Debrosse Zimmermann also noted: “This is a vitally important case, and we must hold these two large companies responsible for what can only be described as gross negligence. Also important, however, is that Judge Pallmeyer is the first judge to ever appoint a black woman as plaintiffs’ co-lead counsel in an MDL. People of color are still underrepresented in the legal profession overall, and especially in first-tier litigation leadership positions. My hope and expectation is that this is only the beginning of a trend for attorneys of color.”

Debrosse Zimmermann co-chairs DiCello Levitt’s mass tort practice group and is a member of the firm’s public client, environmental, personal injury, civil rights, and trial practice groups. Widely known for her passionate and relentless client advocacy, she represents individuals and public entities that have been injured by wrongful conduct, whether from defective medical devices or drugs, environmental contamination, corporate misconduct, or civil rights abuse. She is nationally recognized as a powerhouse in mass torts, class actions, products liability, discrimination, and sexual assault claims, and has recovered hundreds of millions of dollars in client damages.

Earlier this year, Debrosse Zimmermann, was appointed to the Executive Committee in In re: Paraquat Products Liability Litigation, a multidistrict litigation brought by agricultural workers who developed Parkinson’s disease as a result of exposure to the herbicide, Paraquat. She also co-founded the advocacy group, “Shades of Mass,” along with noted civil rights attorney, Ben Crump, with the goal of remedying the lack of diversity in the leadership of litigation that disproportionately impacts diverse communities.

The case is In re: Abbott Laboratories, et al. Preterm Infant Nutrition Products Product Liability Litigation (MDL No. 3026), in the United States District Court for the Northern District of Illinois, Eastern Division.

About DiCello Levitt Gutzler

At DiCello Levitt, we’re dedicated to achieving justice for our clients through mass tort, class action, business-to-business, public client, whistleblower, and personal injury litigation. Our lawyers are highly respected for their ability to litigate and win cases—whether by trial, settlement, or otherwise—for people who have suffered harm, global corporations that have sustained significant economic losses, and public clients seeking to protect their citizens’ rights and interests. Every day, we put our reputations—and our capital—on the line for our clients.

For more, visit our website: https://www.dicellolevitt.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220527005339/en/

Jason Milch

312.379.9406

jmilch@baretzbrunelle.com

Source: DiCello Levitt Gutzler

FAQ

What is the significance of Diandra Debrosse Zimmermann's appointment in the lawsuit against Abbott Laboratories (NYSE: ABT)?

Zimmermann's appointment marks a historic moment as she is the first black woman co-lead counsel in a multidistrict litigation, emphasizing diversity in legal leadership.

What are the allegations against Abbott Laboratories in the products liability case?

Abbott Laboratories is accused of negligence related to its infant formula products, specifically linked to the development of necrotizing enterocolitis (NEC) in premature infants.

How many lawsuits are involved in the MDL against Abbott Laboratories?

The multidistrict litigation involves over 60 state and federal lawsuits filed across the United States.

What are the potential impacts of the litigation on Abbott Laboratories' stock?

If the court rules negatively for Abbott Laboratories, it could result in significant financial liabilities, potentially affecting its stock performance.

What court is overseeing the products liability litigation against Abbott Laboratories?

The case is being overseen by the United States District Court for the Northern District of Illinois.